跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
gD-1
首页
药物
gD-1
gD-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Isolated nucleic acid sequence of equine herpesvirus type 1 glycoprotein D (EHV-1 gD)
申请人: HEALTH RESEARCH INC
优先权: 2000
US
Galactosidase response bimodal probe Gal-Cy-Gd-1 based on methylquinone structure as well as synthesis method and application of galactosidase response bimodal probe Gal-Cy-Gd-1
申请人: INNOVATION ACADEMY FOR PRECISION MEASUREMENT SCIENCE AND TECH CAS
优先权: 2023
CN
重组猫疱疹病毒1型gB-gD蛋白及其应用
申请人: 苏州米迪生物技术有限公司
优先权: 2021
CN
针对猫疱疹病毒1型gD蛋白的特异性抗体及用途
申请人: 北京纳百生物科技有限公司
优先权: 2022
CN
Construction method of recombinant adenovirus with capacity of fusion expression of gene TM-1 and gene gD, recombinant adenovirus and application
申请人: UNIV TIANJIN AGRICULTURAL
优先权: 2017
CN
马疱疹病毒1型gB-gD融合蛋白、重组载体和真核细胞株及其制备方法和疫苗
申请人: 天康制药(苏州)有限公司
优先权: 2018
CN
Anti-glycoprotein D antibody as well as preparation method and application thereof
申请人: VIROGIN BIOTECH CANADA LTD
优先权: 2022
CN
Highly inert Gd-DOTA-based contrast agent with hydrophobic side chain as well as preparation method and application of highly inert Gd-DOTA-based contrast agent
申请人: GUOKE WENZHOU RESEARCH INST WENZHOU INST OF BIOMATERIALS AND ENGINEERING
优先权: 2025
CN
药物
反馈